CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 22,800
-200 (-0.87%)
At close: Aug 14, 2025, 3:30 PM KST
CKD Bio Company Description
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally.
The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business.
It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
CKD Bio Corp.
| Country | South Korea |
| Founded | 1941 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 519 |
Contact Details
Address: 8 Chungjeong-ro Seoul, Gyeonggi-do 03742 South Korea | |
| Phone | 82 2 2194 0555 |
| Website | ckdbio.com |
Stock Details
| Ticker Symbol | 063160 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7063160006 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wan-Kap Park | Co-Chief Executive Officer |
| Hui Yil Kang | Co-Chief Executive Officer, Vice President and Director |